
Three is the magic number after biotech firm Orphazyme has halved its board of directors, which used to count six people, the firm reports in a press release.
The outgoing board members are Stephanie Okey, Carrolee Barlow, and Martin Bonde, and the change is effective today, May 23.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app